Anlotinib or Penpulimab in Combination With RAI for DTC
Clinical trial NCT04952493 · UNKNOWN
Trial details
- NCT number
- NCT04952493
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-15
- Primary completion
- 2023-07-20
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.